Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Financial Flexibility Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Financial Flexibility Index of 1.50x as of December 2024. Free cash flow of CN¥149.55 Million (operating CF CN¥116.38 Million minus capex CN¥33.16 Million) represents 2% of total liabilities (CN¥99.57 Million). Check Medprin Regenerative Medical Technologie (301033) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Medprin Regenerative Medical Technologie.
Annual Financial Flexibility Index for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for Medprin Regenerative Medical Technologies Co. Ltd.. Explore Medprin Regenerative Medical Technologie (301033) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.50x | CN¥149.55 Million | CN¥116.38 Million | CN¥99.57 Million | ▲ +53.6% |
| 2023 | 0.98x | CN¥147.77 Million | CN¥107.69 Million | CN¥151.11 Million | ▼ -24.5% |
| 2022 | 1.29x | CN¥184.27 Million | CN¥48.31 Million | CN¥142.34 Million | ▲ +0.9% |
| 2021 | 1.28x | CN¥219.22 Million | CN¥66.51 Million | CN¥170.92 Million | ▲ +57.4% |
| 2020 | 0.81x | CN¥95.55 Million | CN¥33.91 Million | CN¥117.26 Million | ▼ -55.3% |
| 2019 | 1.82x | CN¥67.98 Million | CN¥31.27 Million | CN¥37.27 Million | — |